Zymtronix Catalytic Systems, Inc. is a biotechnology company headquartered in Durham, North Carolina (originally based in Ithaca, New York). The company develops proprietary magnetic nanomaterial platforms to immobilize enzymes for industrial biocatalysis applications.
Subscribe to see ZYMtronix Catalytic Systems’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
ZYMtronix Catalytic Systems is a biotechnology company headquartered in Durham, United States. Its most recent funding round raised $90M in January 2024. Xcout tracks 5 named people at ZYMtronix Catalytic Systems, including Adam Monroe (CEO).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $90M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of ZYMtronix Catalytic Systems's closest competitors — see the full list of competitors and alternatives →
Immobazyme is a biotechnology company headquartered in Cape Town, South Africa, specializing in enzyme engineering, recombinant protein production, and functional protein manufacturing.
Enzyan Biocatalysis GmbH is a biotechnology company headquartered in Graz, Austria, that specializes in creating innovative biosolutions to synthesize small molecules, particularly nitrogen-containing compounds.
CytoTronics is a biotechnology research company headquartered in Boston, Massachusetts, specializing in cell-based discovery and high-density electrode array technology.
Jurata Thin Film is a biotechnology firm specializing in innovative thin film technology designed to revolutionize biological sample storage and stabilization. The company maintains corporate operations and research facilities in Chapel Hill, North Carolina, and Houston, Texas.
StemoniX, Inc. was a for-profit biotechnology company with its headquarters located in Maple Grove, Minnesota. The firm developed innovative human cellular models and microfluidic technologies for drug discovery and toxicity testing.
Zepteon, Inc. is a biotechnology startup headquartered in Boston, Massachusetts, with operational ties to Dover, Delaware. The company focuses on developing disease-fighting solutions through advanced chromatography resins, aiming to reduce the impact of infectious diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about ZYMtronix Catalytic Systems? Suggest a correction · Work at ZYMtronix Catalytic Systems? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.